$10.88 -0.15 (%) Fluidigm Corp - NASDAQ

Sep. 4, 2015 | 04:00 PM

Partner Headlines

  1. High Throughput Single-Cell mRNA Sequencing Preparation Comes to the Fluidigm C1 System

    Benzinga | Aug. 25, 2015 | 09:01AM EST
  2. Mid-Day Market Update: Friday's Movers, Jobs Report and Interest Rates

    Benzinga | Aug. 7, 2015 | 14:17PM EST
  3. Morning Market Losers

    Benzinga | Aug. 7, 2015 | 09:59AM EST
  4. Thursday's After-Hours Movers Led By Zynga, Nvidia, Nuance And Monster Beverage

    Benzinga | Aug. 6, 2015 | 17:20PM EST
  5. Morning Market Losers

    Benzinga | May. 8, 2015 | 10:02AM EST
  6. Benzinga's Top Downgrades

    Benzinga | May. 8, 2015 | 09:16AM EST
  7. Mizuho Securities Downgrades Fluidigm To Neutral

    Benzinga | May. 8, 2015 | 08:25AM EST
  8. Thursday's After-Hours Movers: NeoPhotonics, Quality Distribution And More

    Benzinga | May. 7, 2015 | 17:49PM EST
  9. Analyst Bullish On Medical Research, Equipment Stocks

    IBD | Apr. 8, 2014 | 13:33PM EST
  10. Fluidigm Announces Proposed $175M Convertible Senior Notes Offering

    Benzinga | Jan. 29, 2014 | 08:32AM EST
  11. Fluidigm Announces Single-Cell DNA Sequencing Workflow to Study Somatic Mutations in Heterogenous Samples

    Benzinga | Dec. 24, 2013 | 09:04AM EST
  12. UPDATE: Oppenheimer Reiterates on Fluidigm on Revised View of Single-Cell Opportunity

    Benzinga | Dec. 5, 2013 | 11:52AM EST
  13. FLUIDIGM

    IBD | Oct. 1, 2013 | 18:39PM EST
  14. Stocks Hitting 52-Week Highs

    Benzinga | Aug. 29, 2013 | 10:09AM EST
  15. Fluidigm Corporation (FLDM) PRESIDENT & CEO Gajus Vincent Worthington sells 10,000 Shares

    GuruFocus | Feb. 5, 2013 | 14:39PM EST
  16. Fluidigm Corporation (FLDM) PRESIDENT & CEO Gajus Vincent Worthington sells 10,000 Shares

    GuruFocus | Jan. 3, 2013 | 14:08PM EST
  17. Fluidigm, Genome Institute of Singapore Establish Asia's First Single-Cell Genomics Research Center

    Benzinga | Dec. 15, 2012 | 01:11AM EST
  18. Fluidigm Corporation (FLDM) PRESIDENT & CEO Gajus Vincent Worthington sells 23,553 Shares

    GuruFocus | Nov. 30, 2012 | 14:37PM EST
  19. Fluidigm Corporation (FLDM) PRESIDENT & CEO Gajus Vincent Worthington sells 8,700 Shares

    GuruFocus | Nov. 28, 2012 | 14:35PM EST
  20. Fluidigm Completes Public Offering of $60M

    Benzinga | Aug. 21, 2012 | 04:17AM EST
  21. Fluidigm Prices $52.2 Million Public Offering of 3.66M Shares of Common Stock

    Benzinga | Aug. 16, 2012 | 03:27AM EST
  22. Fluidigm Announces Proposed Public Offering of Common Stock

    Benzinga | Aug. 15, 2012 | 10:12AM EST
  23. Fluidigm Corp. (FLDM) PRESIDENT & CEO Gajus Vincent Worthington sells 10,000 Shares

    GuruFocus | Aug. 14, 2012 | 18:19PM EST
  24. Technology Sector Wrap

    FoxBusiness | Aug. 8, 2012 | 10:42AM EST
  25. Fluidigm Corp. (FLDM) CFO Vikram Jog sells 5,661 Shares

    GuruFocus | Jul. 11, 2012 | 14:16PM EST
  26. Fluidigm Corp. (FLDM) PRESIDENT & CEO Gajus Vincent Worthington sells 10,000 Shares

    GuruFocus | Jul. 3, 2012 | 14:19PM EST
  27. Winning Trades Based on Analyst Ratings for June 27, 2012

    Benzinga | Jun. 27, 2012 | 09:24AM EST
  28. Fluidigm Corp. (FLDM) PRESIDENT & CEO Gajus Vincent Worthington sells 10,000 Shares

    GuruFocus | Jun. 19, 2012 | 15:23PM EST
  29. Fluidigm Corp. (FLDM) CFO Vikram Jog sells 5,661 Shares

    GuruFocus | Jun. 11, 2012 | 11:20AM EST
  30. Oppenheimer Reiterates Outperform Rating, $19 PT for Fluidigm

    Benzinga | May. 11, 2012 | 11:17AM EST
  31. Fluidigm Corp. (FLDM) CFO Vikram Jog sells 5,661 Shares

    GuruFocus | Feb. 9, 2012 | 08:00AM EST
  32. Fluidigm Corp. (FLDM) President & CEO Gajus Vincent Worthington sells 10,000 Shares

    GuruFocus | Feb. 3, 2012 | 11:32AM EST
  33. From Earlier: Fluidigm and AH Diagnostics Sign Distribution Deal for Scandinavia

    Benzinga | Jan. 31, 2012 | 00:14AM EST
  34. Fluidigm Corp. (FLDM) President & CEO Gajus Vincent Worthington sells 20,000 Shares

    GuruFocus | Jan. 26, 2012 | 14:48PM EST
  35. Benzinga's Volume Gainers

    Benzinga | Jan. 25, 2012 | 08:35AM EST
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!